🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07566520
Starting soon Observational

Prevalence of Sarcopenia and Its Associated Factors in Patients With Knee Osteoarthritis in a Tertiary Care Hospital in Upper Egypt

NCT07566520 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2026-05
Last updated
2026-05-05

Condition(s) studied

OsteoarthritisSarcopenia

Study summary

Osteoarthritis (OA) and sarcopenia are two highly prevalent, interconnected geriatric syndromes that often coexist, leading to a condition termed "osteosarcopenia". Globally, the pooled prevalence of sarcopenia in patients with knee OA is estimated at approximately 25.07%, significantly higher than in the general population.

Eligibility

Sex
ALL
Min age
40 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 40 years and older diagnosed with knee OA based on the American College of Rheumatology (ACR) criteria. * Patients who are willing to participate and provide informed written consent.Exclusion Criteria: * Inflammatory arthritis: patients with rheumatoid arthritis, gouty arthritis, or systemic lupus erythematosus (SLE) to avoid confusion with inflammatory muscle wasting. * Physical Limitations: amputees or those with severe physical deformities preventing gait speed tests or handgrip measurement. * Patients with cardiac pacemakers or implanted electronic devices (as these interfere with Bioelectrical Impedance Analysis (BIA)). * Severe Comorbidities: end-stage renal or hepatic disease, advanced malignancy or cachexia. * Severe neurological disorders (e.g., Parkinson's disease, Stroke with paralysis) that directly affect muscle mass and mobility. * Prolonged use of systemic corticosteroids (which cause secondary sarcopenia)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Assiut University Trauma Hospital Asyut Egypt

More Assiut University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07566520 on ClinicalTrials.gov ↗ ← All trials in Egypt